Inventor

Christopher Breder

Inventor

Bethesda, MD, US

Overview

2006–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 54 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes38%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%

A61JContainers specially adapted for medical or pharmaceutical purposes25%

PatentTitleYear

10,537,526Pharmaceutical formulation containing gelling agent2020 10,500,160Pharmaceutical formulation containing gelling agent2019 10,206,881Pharmaceutical formulation containing gelling agent2019 10,201,547Method of treatment of aggression2019 10,130,586Pharmaceutical formulation containing gelling agent2018 10,076,497Pharmaceutical formulation containing gelling agent2018 10,071,057Pharmaceutical formulation containing gelling agent2018 10,064,825Pharmaceutical formulation containing gelling agent2018 10,064,824Pharmaceutical formulation containing gelling agent2018 10,058,556Method of treatment of aggression2018 9,968,559Pharmaceutical formulation containing gelling agent2018 9,949,930Opioid agonist formulations with releasable and sequestered antagonist2018 9,877,924'Pharmaceutical formulation containing gelling agent'2018 9,872,836Pharmaceutical formulation containing gelling agent2018 9,867,783'Pharmaceutical formulation containing gelling agent'2018 9,867,784'Pharmaceutical formulation containing gelling agent'2018 9,861,583'Pharmaceutical formulation containing gelling agent'2018 9,861,582'Pharmaceutical formulation containing gelling agent'2018 9,808,453'Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent'2017 9,801,887'Method of treatment of aggression'2017 9,757,341'Pharmaceutical formulation containing gelling agent'2017 9,693,961'Pharmaceutical formulation containing gelling agent'2017 9,561,225'Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent'2017 9,522,115'Pharmaceutical formulation containing gelling agent'2016 9,517,206'Pharmaceutical formulation containing gelling agent'2016 9,517,207'Pharmaceutical formulation containing gelling agent'2016 9,498,456'Pharmaceutical formulation containing gelling agent'2016 9,387,174'Pharmaceutical formulation containing gelling agent'2016 9,387,173'Pharmaceutical formulation containing gelling agent'2016 9,308,171'Pharmaceutical formulation containing gelling agent'2016 9,308,170'Pharmaceutical formulation containing gelling agent'2016 9,101,668'Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent'2015 9,060,976'Pharmaceutical formulation containing gelling agent'2015 9,044,435'Pharmaceutical formulation containing gelling agent'2015 9,040,084'Pharmaceutical formulation containing gelling agent'2015 9,034,376'Pharmaceutical formulation containing gelling agent'2015 9,005,659'Pharmaceutical formulation containing gelling agent'2015 8,999,961'Pharmaceutical formulation containing gelling agent'2015 8,871,265'Pharmaceutical formulation containing gelling agent'2014 8,815,287'Opiod agonist formulations with releasable and sequestered antagonist'2014 8,758,825'Sequestered antagonist formulations'2014 8,609,683'Pharmaceutical formulation containing gelling agent'2013 8,529,948'Pharmaceutical formulation containing gelling agent'2013 8,524,275'Pharmaceutical formulations containing opioid agonist, opioid antagonist and gelling agent'2013 8,518,443'Opioid agonist formulations with releasable and sequestered antagonist'2013 8,465,774'Sequestered antagonist formulations'2013 8,389,007'Pharmaceutical composition containing gelling agent'2013 8,337,888'Pharmaceutical formulation containing gelling agent'2012 8,231,901'Opioid agonist formulations with releasable and sequestered antagonist'2012 7,943,173'Pharmaceutical combinations of oxycodone and naloxone'2011 7,914,818'Opioid agonist formulations with releasable and sequestered antagonist'2011 7,842,307'Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent'2010 7,144,587'Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent'2006 7,141,250'Pharmaceutical formulation containing bittering agent'2006

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2020Patents assigned to PURDUE PHARMA LP (46)· patent assignee history

2006–2018Based in Greenwich, CT, US· patent location history

2012–2013Patents assigned to BREDER CHRISTOPHER (6)· patent assignee history

2012–2018Based in Greenwhich, CT, US· patent location history

2013–2020Patents assigned to Purdue Pharmaceuticals LP (33)· patent assignee history

2013–2016Patents assigned to PF LAB INC (14)· patent assignee history

2013–2020Based in Bethesda, MD, US· patent location history

2016–2020Patents assigned to THE P F LABORATORIES INC (19)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
PURDUE PHARMA LP	46	2006–2020
Purdue Pharmaceuticals LP	33	2013–2020
THE P F LABORATORIES INC	19	2016–2020
PF LAB INC	14	2013–2016
BREDER CHRISTOPHERself	6	2012–2013

Locations

Location	Patents	Span
Bethesda, Maryland, US	29	2013–2020
Greenwich, CT, US	19	2006–2018
Greenwhich, CT, US	6	2012–2018